Thu, Nov 12, 2026 - Page 63
13819 indexed SquawkNews stories from this UTC day. Showing 7441-7560.
L
Canada's NeuPath Health Q3 revenue rises 1%, patient visits up 7%
Canada's NeuPath Health Q3 revenue rises 1%, patient visits up 7% Overview Canada pain clinic operat
EARNINGS | Nov 12, 2026, 12:40 PM UTC
H
Brazil inflation remains above goal despite softer-than-expected October reading
Consumer prices in Brazil rose less than expected in the 12 months through October but remained above the central bank's target range, as policymakers vow to keep using high interest rates to rein in persistent inflation
CENTRAL_BANK | Nov 12, 2026, 12:40 PM UTC
H
UPDATE 1-Brazil inflation remains above goal despite softer-than-expected October reading
UPDATE 1-Brazil inflation remains above goal despite softer-than-expected October reading New throug
MACRO | Nov 12, 2026, 12:40 PM UTC
L
ENCORE ENERGY CORP - Q3 REVENUE INCREASED 88% YEAR OVER YEAR TO $16.70 MLN
ENCORE ENERGY CORP - Q3 REVENUE INCREASED 88% YEAR OVER YEAR TO $16.70 MLN
EARNINGS | Nov 12, 2026, 12:40 PM UTC
L
Capstone Reports Q3 2026 Results: Revenue Up 46% to $20.0 Million, Gross Profit Up 76%, Operating Income of $0.4 Million
Capstone Holding Corp. (NASDAQ:CAPS), a national, technology-enabled building products distribution platform, today reported that third-quarter revenue grew 46% year over year to $20.0 million, compared with $13.7 millio
EARNINGS | Nov 12, 2026, 12:40 PM UTC
L
ENCORE ENERGY CORP - Q3 NET LOSS ATTRIBUTABLE TO ENCORE $33.90 MLN, OR $0.17 PER SHARE
ENCORE ENERGY CORP - Q3 NET LOSS ATTRIBUTABLE TO ENCORE $33.90 MLN, OR $0.17 PER SHARE
EQUITY | Nov 12, 2026, 12:40 PM UTC
L
Capstone Reports Q3 2026 Results: Revenue Up 46% to $20.0 Million, Gross Profit Up 76%, Operating Income of $0.4 Million
Full-year Stone Business Adjusted EBITDA expected to more than triple, and each operating business o
EARNINGS | Nov 12, 2026, 12:40 PM UTC
L
CAPSTONE REPORTS Q3 2026 RESULTS: REVENUE UP 46% TO $20.0 MILLION, GROSS PROFIT UP 76%, OPERATING INCOME OF $0.4 MILLION
CAPSTONE REPORTS Q3 2026 RESULTS: REVENUE UP 46% TO $20.0 MILLION, GROSS PROFIT UP 76%, OPERATING IN
EARNINGS | Nov 12, 2026, 12:40 PM UTC
L
Freedom Broker Raises MDU Resources to Buy From Hold
Freedom Broker raised its price target for MDU Resources Group to $23.00 per share from $21.00.
EQUITY | Nov 12, 2026, 12:39 PM UTC
L
ASSOCIATED ALCOHOLS & BREWERIES LTD Q2 CONSOL REVENUE FROM OPS INR 2,769.6 MILLION
ASSOCIATED ALCOHOLS & BREWERIES LTD Q2 CONSOL REVENUE FROM OPS INR 2,769.6 MILLION
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
Solo Brands Q3 sales fall on lower segment demand
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EQUITY | Nov 12, 2026, 12:39 PM UTC
L
Solo Brands Q3 sales fall on lower segment demand
Solo Brands Q3 sales fall on lower segment demand Overview Premium outdoor lifestyle firm's Q3 net s
EQUITY | Nov 12, 2026, 12:39 PM UTC
L
Generate Biomedicines Q3 net loss widens 46% year over year to $87.7 million; Q3 revenue falls 56% year over year to $4.2 million
Generate Biomedicines Q3 net loss widens 46% year over year to $87.7 million; Q3 revenue falls 56% y
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
ASSOCIATED ALCOHOLS & BREWERIES LTD Q2 CONSOL NET PROFIT INR 80 MILLION
ASSOCIATED ALCOHOLS & BREWERIES LTD Q2 CONSOL NET PROFIT INR 80 MILLION
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
Canada's Bridgemarq Q3 revenue falls 12% on real estate market weakness
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
NEXXEN INTERNATIONAL - Q3 2026 PROGRAMMATIC REVENUE $97.80 MLN, UP 9% YEAR-OVER-YEAR
NEXXEN INTERNATIONAL - Q3 2026 PROGRAMMATIC REVENUE $97.80 MLN, UP 9% YEAR-OVER-YEAR
EARNINGS | Nov 12, 2026, 12:39 PM UTC
H
Twist Bioscience Announces Availability of Fiscal 2026 Fourth-Quarter and Full-Year Earnings Report
Twist Bioscience Announces Availability of Fiscal 2026 Fourth-Quarter and Full-Year Earnings Report
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
Canada's Bridgemarq Q3 revenue falls 12% on real estate market weakness
Canada's Bridgemarq Q3 revenue falls 12% on real estate market weakness Overview Canada real estate
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
Intuitive Machines Q3 revenue beats estimates on satellite production business
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 12:39 PM UTC
M
Intuitive Machines Shares Rise 12.3% Premarket After Q3 Revenue Beat
The company also reported a narrower net loss.
EQUITY | Nov 12, 2026, 12:39 PM UTC
H
Parabilis Medicines: Q3 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass.
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
China welcomes deeper investment cooperation with Invesco
A Chinese vice premier said China welcomes deeper investment cooperation with Invesco.
EQUITY | Nov 12, 2026, 12:39 PM UTC
L
Canada's MediPharm Labs Q3 revenue rises 18% on international medical growth
OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re
EARNINGS | Nov 12, 2026, 12:39 PM UTC
H
EROCK - REAFFIRMS FULL-YEAR 2026 GUIDANCE
EROCK - REAFFIRMS FULL-YEAR 2026 GUIDANCE
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
Charlotte's Web Q3 net loss narrows 41% year over year to USD 3.46 million; Q3 revenue falls 18% year over year to USD 9.39 million
Charlotte's Web Q3 net loss narrows 41% year over year to USD 3.46 million; Q3 revenue falls 18% yea
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
Canada's MediPharm Labs Q3 revenue rises 18% on international medical growth
Canada's MediPharm Labs Q3 revenue rises 18% on international medical growth Overview Canadian canna
EARNINGS | Nov 12, 2026, 12:39 PM UTC
L
Taysha Gene Therapies Q3 net loss widens on higher R&D costs
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 12:38 PM UTC
L
Jeudan Q3 2026 Pretax Profit Rises to DKK 877.51 Million Year Over Year
Jeudan Q3 2026 Pretax Profit Rises to DKK 877.51 Million Year Over Year Jeudan’s net profit rose
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Taysha Gene Therapies Q3 net loss widens on higher R&D costs
Taysha Gene Therapies Q3 net loss widens on higher R&D costs Overview US gene therapy developer's Q3
EQUITY | Nov 12, 2026, 12:38 PM UTC
L
Luggage maker Samsonite's Q3 revenue beats expectations; sets stock buyback plan
OverviewOutlookResult DriversKey DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Visa Chrome Reports September-Quarter Operating Revenue of 1.35 Billion Rupees
Visa Chrome reported consolidated revenue from operations of 1.35 billion rupees for the September quarter.
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Luggage maker Samsonite's Q3 revenue beats expectations; sets stock buyback plan
Luggage maker Samsonite's Q3 revenue beats expectations; sets stock buyback plan Overview Luggage ma
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Intuitive Machines Sees FY26 as Adjusted EBITDA Positive >LUNR
Intuitive Machines Sees FY26 as Adjusted EBITDA Positive >LUNR
EQUITY | Nov 12, 2026, 12:38 PM UTC
L
Altimmune posts higher than expected Q3 loss
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 12:38 PM UTC
L
Visa Chrome reports September-quarter consolidated net loss of 219.4 million rupees
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Altimmune posts higher than expected Q3 loss
Altimmune posts higher than expected Q3 loss Overview US biopharma firm's Q3 net loss and loss per
EQUITY | Nov 12, 2026, 12:38 PM UTC
H
HLS THERAPEUTICS - 2026 CONSOLIDATED REVENUE GUIDANCE $56 MLN-$60 MLN, EXPECTS MIDPOINT
HLS THERAPEUTICS - 2026 CONSOLIDATED REVENUE GUIDANCE $56 MLN-$60 MLN, EXPECTS MIDPOINT
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Intuitive Machines Sees FY26 Rev $920M-$950M >LUNR
Intuitive Machines Sees FY26 Rev $920M-$950M >LUNR
EQUITY | Nov 12, 2026, 12:38 PM UTC
L
US Dollar Falls Ahead of Jobless Claims and Home Sales Data
The US dollar fell against its major trading partners early Thursday ahead of jobless claims and existing home sales data.
FX | Nov 12, 2026, 12:38 PM UTC
L
ERock Q3 2026 net income swings to $8.9 million from year-earlier loss
ERock Q3 2026 net income swings to $8.9 million from year-earlier loss ERock swung to third-quar
EQUITY | Nov 12, 2026, 12:38 PM UTC
H
*--Earnings Flash (ASND) Ascendis Pharma Posts Q3 Non-IFRS EPS 1.71 Euros
*--Earnings Flash (ASND) Ascendis Pharma Posts Q3 Non-IFRS EPS 1.71 Euros
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Canada LNG goal could spur nearly C$1 trillion in investment by 2050
S&P Global says Canada's LNG export goal could spur nearly C$1 trillion in investment by 2050.
ENERGY | Nov 12, 2026, 12:38 PM UTC
L
DiaSorin Q3 adjusted EBITDA rises 16% to EUR 103 million
DiaSorin Q3 adjusted EBITDA rises 16% to EUR 103 million DiaSorin’s third-quarter 2026 adjusted
FX | Nov 12, 2026, 12:38 PM UTC
M
NIQ Raises 2026 Adjusted EPS Guidance to $1.16-$1.20
NIQ raised its full-year 2026 adjusted EPS guidance to $1.16-$1.20.
EARNINGS | Nov 12, 2026, 12:38 PM UTC
L
Intuitive Machines Ended 3Q With Backlog of $1.9 B >LUNR
Intuitive Machines Ended 3Q With Backlog of $1.9 B >LUNR
EQUITY | Nov 12, 2026, 12:37 PM UTC
M
Nebius Group Sees FY27 Revenue of $12B-$13B
EARNINGS | Nov 12, 2026, 12:37 PM UTC
L
Takeda Launches Sleep Disorder Pill in the US After DEA Clearance
EQUITY | Nov 12, 2026, 12:37 PM UTC
L
KeyBanc Cuts Nvidia to Sector Weight From Overweight
EQUITY | Nov 12, 2026, 12:37 PM UTC
H
*--GUIDANCE: (LUNR) Intuitive Machines Expects 2026 Revenue Range $920M - $950M, vs. FactSet Est of $925.8M
*--GUIDANCE: (LUNR) Intuitive Machines Expects 2026 Revenue Range $920M - $950M, vs. FactSet Est of $925.8M
EARNINGS | Nov 12, 2026, 12:37 PM UTC
L
Sagimet Biosciences Q3 net loss widens on higher R&D costs
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 12:37 PM UTC
L
Cyngn Q3 2026 Net Loss Narrows 29% to $5.96 Million
Cyngn Q3 2026 Net Loss Narrows 29% to $5.96 Million Cyngn’s third-quarter 2026 net loss narrowed
EQUITY | Nov 12, 2026, 12:37 PM UTC
L
Sagimet Biosciences Q3 net loss widens on higher R&D costs
Sagimet Biosciences Q3 net loss widens on higher R&D costs Overview Biopharma firm's Q3 net loss wid
EQUITY | Nov 12, 2026, 12:37 PM UTC
L
Ascendis Pharma A/S (ASND) Q3 Revenue Rose 73% To €370M
Q3 2026 revenue was €370M versus €214M in Q3 2025. Operating profit was €125M versus €11M, and net profit was €74M versus a €61M net loss.Material DetailsContext by AI AnalystThis quarter provides financial confirmation
EARNINGS | Nov 12, 2026, 12:37 PM UTC
L
MediPharm Labs Corp. (LABS) Reports 18% Sequential Revenue Growth and Positive Net Income
MediPharm Labs reported Q3 2026 revenue up 18% from Q2 2026, with revenue, gross profit and Adjusted EBITDA higher than Q3 2025. It reported positive net income for a second consecutive quarter and positive Adjusted EBIT
EARNINGS | Nov 12, 2026, 12:37 PM UTC
L
Ascendis Pharma Reports Third Quarter 2026 Financial Results
COPENHAGEN, Denmark, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S NASDAQ:ASND today announced financial results for the third quarter ended September 30, 2026, and provided a business update.“By always putting p
EQUITY | Nov 12, 2026, 12:37 PM UTC
H
*--Earnings Flash (LUNR) Intuitive Machines Posts Q3 Loss $0.02 a Share, vs. FactSet Est of $0.10 Loss
*--Earnings Flash (LUNR) Intuitive Machines Posts Q3 Loss $0.02 a Share, vs. FactSet Est of $0.10 Loss
EARNINGS | Nov 12, 2026, 12:37 PM UTC
L
MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth
TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. TSX:LABS OTCQB:MEDIF FSE:MLZ ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today a
EARNINGS | Nov 12, 2026, 12:37 PM UTC
H
Generate Biomedicines: Q3 Earnings Snapshot
SOMERVILLE, Mass. (AP) — SOMERVILLE, Mass.
EARNINGS | Nov 12, 2026, 12:37 PM UTC
L
Reply Q3 2026 pre-tax profit rises 10% year-on-year to €97.45 million
Reply Q3 2026 pre-tax profit rises 10% year-on-year to €97.45 million Reply’s third-quarter 2026
EARNINGS | Nov 12, 2026, 12:37 PM UTC
L
AVEANNA HEALTHCARE HOLDINGS INC FY2026 REV VIEW $2.69 BLN -- LSEG IBES DATA
AVEANNA HEALTHCARE HOLDINGS INC FY2026 REV VIEW $2.69 BLN -- LSEG IBES DATA
EQUITY | Nov 12, 2026, 12:37 PM UTC
L
BRIEF-Loyal Textile Mills Q2 Consol Net Profit INR 800,000
BRIEF-Loyal Textile Mills Q2 Consol Net Profit INR 800,000 Nov 12 (Reuters) - Loyal Textile Mills Q2
EARNINGS | Nov 12, 2026, 12:37 PM UTC
M
Aveanna Healthcare Raises 2026 Revenue Guidance as Q3 Earnings and Revenue Rise
EQUITY | Nov 12, 2026, 12:36 PM UTC
H
View: Nvidia is officially too big to fail
Nvidia is an AI-rollup machine “You want ‘too big to fail,’ here it is!” the small-screen version of Hank Paulson screams in HBO’s 2011 film as he stares down AIG’s failure. The plane that had shuttled him to an emergenc
CENTRAL_BANK | Nov 12, 2026, 12:36 PM UTC
L
IRCTC Q2 Results: Net profit falls 23% as Rail Neer swings to loss, catering profit declines
Railway PSU Indian Railway Catering and Tourism Corporation Ltd (IRCTC) on Thursday (November 12) reported a 22.9% year-on-year decline in net profit to ₹263.6 crore for the second quarter of FY27, compared with ₹342 cro
EARNINGS | Nov 12, 2026, 12:36 PM UTC
L
Takeda launches ORZEYFUL in US for narcolepsy type 1
ORZEYFUL (oveporexton) is available by prescription in the US for adults with narcolepsy type 1.
EQUITY | Nov 12, 2026, 12:36 PM UTC
M
Installed Building Products Acquires Old Dominion Group
Installed Building Products said it is expanding its commercial and industrial platform with the acquisition of Old Dominion Group.
EQUITY | Nov 12, 2026, 12:36 PM UTC
M
JD.com Acquires 59.8% of Ceconomy Share Capital and Voting Rights
EQUITY | Nov 12, 2026, 12:36 PM UTC
M
Oil Prices Lower as Rising Crude Output Offsets Geopolitical Risks
ENERGY | Nov 12, 2026, 12:36 PM UTC
L
Romania sells 600.7 mln lei of 6-month T-bills and 655.1 mln lei of July 2033 bonds
Romania sells 600.7 mln lei of 6-month T-bills and 655.1 mln lei of July 2033 bonds Nov 12 (Reuters)
RATES | Nov 12, 2026, 12:36 PM UTC
H
ENOVIX CORPORATION - ISSUES FY2027 REVENUE GUIDANCE OF $65 MLN-$85 MLN
ENOVIX CORPORATION - ISSUES FY2027 REVENUE GUIDANCE OF $65 MLN-$85 MLN
EARNINGS | Nov 12, 2026, 12:36 PM UTC
L
Absci Q3 2026 net loss widens 16% year over year to $33.3 million
Absci Q3 2026 net loss widens 16% year over year to $33.3 million Absci's third-quarter 2026 net
EQUITY | Nov 12, 2026, 12:36 PM UTC
L
LOYAL TEXTILE MILLS LTD Q2 CONSOL REVENUE FROM OPS INR 906.7 MILLION
LOYAL TEXTILE MILLS LTD Q2 CONSOL REVENUE FROM OPS INR 906.7 MILLION
EARNINGS | Nov 12, 2026, 12:36 PM UTC
L
ASCENDIS PHARMA Q3 REVENUE EUR 369.657 MILLION
ASCENDIS PHARMA Q3 REVENUE EUR 369.657 MILLION
EARNINGS | Nov 12, 2026, 12:36 PM UTC
L
BASE CARBON Q3 EPS $0.02
BASE CARBON Q3 EPS $0.02
EARNINGS | Nov 12, 2026, 12:36 PM UTC
H
*--Earnings Flash (ASND) Ascendis Pharma Posts Q3 Revenue 369.7M Euros, vs. FactSet Est of 361.4M Euros
*--Earnings Flash (ASND) Ascendis Pharma Posts Q3 Revenue 369.7M Euros, vs. FactSet Est of 361.4M Euros
EARNINGS | Nov 12, 2026, 12:36 PM UTC
L
ERock 3Q Rev $152.8M >EROC
ERock 3Q Rev $152.8M >EROC
EQUITY | Nov 12, 2026, 12:36 PM UTC
L
BASE CARBON - ENDS Q3 2026 WITH TOTAL ASSETS OF $105.80 MLN INCLUDING $2.50 MLN CASH, $13.50 MLN CARBON CREDIT INVENTORY
BASE CARBON - ENDS Q3 2026 WITH TOTAL ASSETS OF $105.80 MLN INCLUDING $2.50 MLN CASH, $13.50 MLN CAR
EQUITY | Nov 12, 2026, 12:35 PM UTC
L
LOYAL TEXTILE MILLS LTD Q2 CONSOL NET PROFIT INR 800 THOUSAND
LOYAL TEXTILE MILLS LTD Q2 CONSOL NET PROFIT INR 800 THOUSAND
EARNINGS | Nov 12, 2026, 12:35 PM UTC
L
ASCENDIS PHARMA Q3 EPS EUR 1.08
ASCENDIS PHARMA Q3 EPS EUR 1.08
EARNINGS | Nov 12, 2026, 12:35 PM UTC
M
Nebius AI cloud revenue rises 643% to $973.8 million in Q3
Nebius Group reported AI cloud revenue of $973.8 million in Q3, up 643%.
EQUITY | Nov 12, 2026, 12:35 PM UTC
L
CORMEDIX Q3 REVENUE USD 54.519 MILLION VS. IBES ESTIMATE USD 52.3 MILLION
CORMEDIX Q3 REVENUE USD 54.519 MILLION VS. IBES ESTIMATE USD 52.3 MILLION
EARNINGS | Nov 12, 2026, 12:35 PM UTC
L
SUBURBAN PROPANE PARTNERS Q4 EPS USD -0.85
SUBURBAN PROPANE PARTNERS Q4 EPS USD -0.85
EARNINGS | Nov 12, 2026, 12:35 PM UTC
H
Legence: Q3 Earnings Snapshot
SAN JOSE, Calif. (AP) — SAN JOSE, Calif.
EARNINGS | Nov 12, 2026, 12:35 PM UTC
L
STRATASYS LTD. FY2026 SHR VIEW $0.11, REV VIEW $565.2 MLN -- LSEG IBES DATA
STRATASYS LTD. FY2026 SHR VIEW $0.11, REV VIEW $565.2 MLN -- LSEG IBES DATA
EQUITY | Nov 12, 2026, 12:35 PM UTC
L
Medipharm Labs 3Q Rev C$11.8 >LABS.T
Medipharm Labs 3Q Rev C$11.8 >LABS.T
EQUITY | Nov 12, 2026, 12:35 PM UTC
H
*-- Earnings Flash (BRE.TO) Bridgemarq Real Estate Services Posts Q3 Adjusted EPS CA$0.07
*-- Earnings Flash (BRE.TO) Bridgemarq Real Estate Services Posts Q3 Adjusted EPS CA$0.07
EARNINGS | Nov 12, 2026, 12:35 PM UTC
H
Putin warns foreign troops in Ukraine would be targeted - IFX
Putin warns foreign troops in Ukraine would be targeted - IFX
GEOPOLITICS | Nov 12, 2026, 12:34 PM UTC
L
Boost Run 3Q Operating Cash Flow Was $65.6 M >BRUN
Boost Run 3Q Operating Cash Flow Was $65.6 M >BRUN
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
Twist Bioscience Q4 revenue beats analyst expectations
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 12:34 PM UTC
L
EyePoint Q3 2026 net loss widens 60% to $95.6 million
EyePoint Q3 2026 net loss widens 60% to $95.6 million EyePoint’s third-quarter 2026 net loss wid
EQUITY | Nov 12, 2026, 12:34 PM UTC
M
Serco to Acquire QinetiQ’s U.S. Business for $292 Million
Serco Group is buying QinetiQ’s U.S. business for $292 million to build its U.S. defense platform. BNP Paribas analyst Daniel Cowan calls the deal timely and attractive.
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
Twist Bioscience Q4 revenue beats analyst expectations
Twist Bioscience Q4 revenue beats analyst expectations Overview Synthetic DNA firm's fiscal Q4 reven
EARNINGS | Nov 12, 2026, 12:34 PM UTC
L
CORRECTED-NEUPATH HEALTH Q3 ADJUSTED EBITDA CAD 1.388 MILLION (CORRECTS AMOUNT)
CORRECTED-NEUPATH HEALTH Q3 ADJUSTED EBITDA CAD 1.388 MILLION (CORRECTS AMOUNT)
FX | Nov 12, 2026, 12:34 PM UTC
L
BRIDGEMARQ REAL ESTATE SERVICES INC: REMAIN CONFIDENT IN LONG-TERM OUTLOOK FOR CANADIAN RESIDENTIAL REAL ESTATE MARKET
BRIDGEMARQ REAL ESTATE SERVICES INC: REMAIN CONFIDENT IN LONG-TERM OUTLOOK FOR CANADIAN RESIDENTIAL
EQUITY | Nov 12, 2026, 12:34 PM UTC
M
Nebius Q3 revenue reaches $980.8 million
Nebius Group reported Q3 revenue of USD 980.8 million versus the IBES estimate of USD 907.5 million.
EQUITY | Nov 12, 2026, 12:34 PM UTC
H
ERock, Inc. (EROC) Reports $8.9M Net Income and Reaffirms 2026 Guidance
ERock reported $8.9M of net income and $12.6M of Adjusted EBITDA for Q3 2026, its first profitable quarter as a public company. It reaffirmed full-year 2026 guidance; revenue outlook midpoint represents approximately 2.5
EARNINGS | Nov 12, 2026, 12:34 PM UTC
M
Terna Core Profit Rises 7.2% to €2.17 Billion in Nine Months
Italian grid operator Terna said core profit rose 7.2% to €2.17 billion in the first nine months of 2026, while capital spending reached a record €2.35 billion.
EARNINGS | Nov 12, 2026, 12:34 PM UTC
L
Jefferies Raises Pattern Group to Buy From Hold
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
Canadian Tire Sees Early Sales Boost From Tim Hortons Rewards Partnership — Market Talk
Canadian Tire's rewards programs are contributing to sales growth. CEO Greg Hicks highlights early momentum from Canadian Tire's loyalty partnership with coffee-and-donut chain Tim Hortons, which launched in early Septem
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
ERock 3Q EPS 4c >EROC
ERock 3Q EPS 4c >EROC
EARNINGS | Nov 12, 2026, 12:34 PM UTC
L
Avicanna 3Q Rev C$5.73M >AVCN.T
Avicanna 3Q Rev C$5.73M >AVCN.T
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
ERock Reports Third Quarter 2026 Results
ERock, Inc. (NYSE:EROC) (“ERock” or the “Company”), a leading provider of utility-grade onsite power solutions, today reported financial and operating results for the third quarter ended September 30, 2026, highlighted b
EARNINGS | Nov 12, 2026, 12:34 PM UTC
L
ERock Reports Third Quarter 2026 Results
Revenue Increased Nearly 4x Quarter-over-Quarter, Driving Positive Net Income and Adjusted EBITDA Re
EARNINGS | Nov 12, 2026, 12:34 PM UTC
L
EROCK REPORTS THIRD QUARTER 2026 RESULTS
EROCK REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
Bridgemarq Real Estate Confident in te Long-Term Outlook for Canadian Residential Real Estate Market >BRE.T
Bridgemarq Real Estate Confident in te Long-Term Outlook for Canadian Residential Real Estate Market >BRE.T
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
Intuitive Machines 3Q Loss/Shr 2c >LUNR
Intuitive Machines 3Q Loss/Shr 2c >LUNR
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
Intuitive Machines 3Q Rev $269.3M >LUNR
Intuitive Machines 3Q Rev $269.3M >LUNR
EQUITY | Nov 12, 2026, 12:34 PM UTC
L
CVS Group Keeps Critical Antibiotic Prescriptions at 1.5% of Consultations
EQUITY | Nov 12, 2026, 12:34 PM UTC
M
CorMedix Says It Believes 2027 DefenCath Revenue Guidance Should Be Suspended
CorMedix said it believes suspending previously issued 2027 DefenCath revenue guidance is appropriate and will defer future guidance until early 2027.
EARNINGS | Nov 12, 2026, 12:33 PM UTC
L
CorMedix 3Q Rev $54.5M >CRMD
CorMedix 3Q Rev $54.5M >CRMD
EQUITY | Nov 12, 2026, 12:33 PM UTC
M
Bridgemarq Real Estate reports C$1.1M adjusted net income for Q3
EARNINGS | Nov 12, 2026, 12:33 PM UTC
M
Brookfield Q3 Distributable Earnings Per Share Rise 16% to USD 0.73
EQUITY | Nov 12, 2026, 12:33 PM UTC
L
SAGIMET BIOSCIENCES Q3 EPS USD -0.31
SAGIMET BIOSCIENCES Q3 EPS USD -0.31
EARNINGS | Nov 12, 2026, 12:33 PM UTC
H
Russia Pres Putin: Presence Of Foreign Troops In Ukraine Is Unacceptable — IFX
Russia Was Never Against Dialogue With Europe - Possibility Of Foreign Troops Being Present In Ukraine Poses A Threat To National Security Of Russia
GEOPOLITICS | Nov 12, 2026, 12:33 PM UTC
L
SPML Infra appoints Arun Kumar Agarwal as CFO
The appointment is effective Dec. 1, 2026.
EQUITY | Nov 12, 2026, 12:33 PM UTC
M
Cellebrite Q3 Non-GAAP Earnings and Revenue Rise; 2026 Revenue Guidance Lowered
Cellebrite reported higher Q3 non-GAAP earnings and revenue and lowered its 2026 revenue guidance.
EQUITY | Nov 12, 2026, 12:33 PM UTC
H
Legence Reports 85% Revenue Growth, $177 Million Adjusted EBITDA in Q3 2026
Legence reported third-quarter 2026 revenue of $1.31 billion, up 85.1% year over year, and net income attributable to Legence of $89.6 million. Adjusted EBITDA rose 99.3% to $177.0 million, while the company raised its 2
EARNINGS | Nov 12, 2026, 12:33 PM UTC
L
Yesway Reports $24.8 Million in Third-Quarter Net Income
Yesway reported third-quarter 2026 revenue of $969.2 million and net income of $24.8 million, compared with $715.9 million and $15.9 million, respectively, a year earlier. Adjusted EBITDA rose 8.6% to $59.6 million. The
EARNINGS | Nov 12, 2026, 12:33 PM UTC
L
CorMedix 3Q Loss $14.7M >CRMD
CorMedix 3Q Loss $14.7M >CRMD
EQUITY | Nov 12, 2026, 12:33 PM UTC
H
Hudbay Minerals Inc. Reports Third Quarter 2026 Financial Results
Hudbay Minerals Inc. reported strong financial performance for the third quarter of 2026, achieving record revenue of $766 million and adjusted EBITDA of $413 million. The company's consolidated copper production reached
EARNINGS | Nov 12, 2026, 12:33 PM UTC